DENTSPLY SIRONA stock analysis
DENTSPLY SIRONA (0I8F) Share Price & Analysis
0I8F Stock Chart & Stats
- Day’s Range
- $8.92 - $9.21
- 52-Week Range
- $8.15 - $14.66
- Previous Close
- $9.29
- Volume
- N/A
- Average Volume (3M)
- 5,132
- Market Cap
- $1.77B
- Enterprise Value
- $3.86B
- Total Cash (Recent Filing)
- $195.00M
- Total Debt (Recent Filing)
- $2.29B
- Price to Earnings (P/E)
- ―
- Beta
- 1.42
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- 0.32
- Last Dividend Ex-Date
- Dec 26, 2025
- Dividend Yield
- 7.16%
Bulls Say, Bears Say
Bulls Say
Wellspect Growth
Wellspect’s record sales and double-digit growth provide evidence of product-market traction within a focused healthcare business. Continued volume gains, new-product adoption, and expanded Medicare coverage could support a more durable growth engine and diversify performance beyond pressured dental segments.
Commercial And Product Investment
Higher R&D investment, customer-informed development, and new product approvals strengthen DENTSPLY SIRONA’s innovation pipeline. These efforts can improve clinical relevance, broaden the addressable product range, and support customer adoption over multiple quarters if commercial execution converts development into sales.
Margin And Cost Actions
Gross-margin improvement and a sizable savings program show that management is making measurable progress on operational efficiency. If savings are sustained without impairing commercial investment, they can help offset softer volumes, improve earnings conversion, and support eventual profitability recovery.
Bears Say
Declining Revenue And Losses
Persistent revenue contraction across a multi-year period indicates that the recovery has not yet translated into broad-based demand improvement. Continued net losses limit internal reinvestment capacity and make future earnings more dependent on successful execution of restructuring and growth initiatives.
Leverage And Weakening Cash Flow
Elevated leverage combined with negative returns on equity reduces financial flexibility while the business is still unprofitable. Weaker free cash flow also narrows the cushion available for debt service, investment, and shareholder returns, increasing execution pressure if the earnings recovery stalls.
Lowered Outlook And Segment Pressure
Reduced full-year revenue and EPS expectations confirm that current operational improvements are not yet overcoming broad demand and segment pressures. Lower guidance can constrain near-term planning confidence and indicates that the return-to-growth program still needs sustained execution before results become dependable.
DENTSPLY SIRONA News
0I8F FAQ
What was DENTSPLY SIRONA’s price range in the past 12 months?
What is DENTSPLY SIRONA’s market cap?
When is DENTSPLY SIRONA’s upcoming earnings report date?
How were DENTSPLY SIRONA’s earnings last quarter?
Is DENTSPLY SIRONA overvalued?
Does DENTSPLY SIRONA pay dividends?
What is DENTSPLY SIRONA’s EPS estimate?
How many shares outstanding does DENTSPLY SIRONA have?
What happened to DENTSPLY SIRONA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of DENTSPLY SIRONA?
What is the TipRanks Smart Score and how is it calculated?
DENTSPLY SIRONA Stock Smart Score
Company Description
DENTSPLY SIRONA
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Daniel T. Scavilla
- Employees
- 14,000
- Website
- www.dentsplysirona.com
- Address
- 13320 Ballantyne Corporate Place, Charlotte, NC, 28277-3607, US
DENTSPLY SIRONA (0I8F) Earnings & Revenues
0I8F Company Deck
0I8F Earnings Call
Earnings Call SentimentNeutral
The call was mixed but leaned positive on operational progress. The company reported significant momentum at Wellspect and in selected U.S. businesses, along with stronger commercial coverage, increased clinical education, product approvals, and cost-saving initiatives. However, these developments were outweighed in the near term by a 7.6% reported revenue decline, lower adjusted EPS, reduced full-year guidance, weaker cash flow, and continued pressure across several dental segments and international markets.
View all GB:0I8F earnings summaries0I8F Net sales Breakdown
- 15.71% Equipment & Instruments
- 12.45% CAD/CAM
- 39.92% Essential Dental Solutions
- 6.17% Orthodontics
- 16.93% Implants & Prosthetics
- 8.83% Wellspect Healthcare
0I8F Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |












